STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized

STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized →

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow digital health companies to release products without marketing authorization.